Bleeding risk factors associated with argatroban therapy in the critically ill-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Bleeding risk factors associated with argatroban therapy in the critically ill

Published:2012-06-29 Issue:4 Volume:34 Page:491-498
ISSN:0929-5305
Container-title:Journal of Thrombosis and Thrombolysis
language:en
Short-container-title:J Thromb Thrombolysis

Author:

Doepker Bruce,Mount Kari L.,Ryder Lindsay J.,Gerlach Anthony T.,Murphy Claire V.,Philips Gary S.

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,Hematology

Link

http://link.springer.com/content/pdf/10.1007/s11239-012-0758-y.pdf

Reference26 articles.

1. Beiderlinden M et al (2007) Argatroban anticoagulation in critically ill patients. Ann Pharmacother 41(5):749–754

2. Dager WE, White RH (2002) Treatment of heparin-induced thrombocytopenia. Ann Pharmacother 36(3):489–503

3. Warkentin TE et al (2008) Treatment and prevention of heparin-induced thrombocytopenia: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition). Chest 133(6 Suppl):340S–380S

4. Selleng K, Warkentin TE, Greinacher A (2007) Heparin-induced thrombocytopenia in intensive care patients. Crit Care Med 35(4):1165–1176

5. Hirsh J et al (2008) Parenteral anticoagulants: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition). Chest 133(6 Suppl):141S–159S

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery and Characterization of Panaxatriol as a Novel Thrombin Inhibitor from Panax notoginseng Using a Combination of Computational and Experimental Approaches;Planta Medica;2024-06-05

2. Head-to-head ex vivo comparison of clinically used direct anticoagulant drugs;Naunyn-Schmiedeberg's Archives of Pharmacology;2023-12-19

3. Thromboprophylaxis with argatroban in critically ill patients with sepsis: a review;Blood Coagulation & Fibrinolysis;2022-06-08

4. Superior outcomes with Argatroban for heparin-induced thrombocytopenia: a Bayesian network meta-analysis;International Journal of Clinical Pharmacy;2021-03-28

5. Risk factors for ecchymosis in patients receiving rivaroxaban for thromboprophylaxis after total knee arthroplasty: a retrospective cohort study;Journal of Clinical Pharmacy and Therapeutics;2021-03-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3